Drug Profile
Morphine oral - Elan Corporation
Alternative Names: AvinzaLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Elan Corporation
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pain
Most Recent Events
- 18 Dec 2013 Elan Corporation has been acquired and merged into Perrigo
- 01 Mar 2011 King Pharmaceuticals has been acquired and merged into Pfizer
- 18 Sep 2006 King Pharmaceuticals is to acquire rights to Avinza™ from Ligand Pharmaceuticals for the USA and Canada